ID

39270

Description

Study of the Product QGC001 as a Single Dose and Multiple Doses Administered Orally to Healthy Adult Subjects; ODM derived from: https://clinicaltrials.gov/show/NCT01900184

Link

https://clinicaltrials.gov/show/NCT01900184

Keywords

Versions (1)
  1. 12/15/19 12/15/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

December 15, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Essential Hypertension NCT01900184

English

Eligibility Essential Hypertension NCT01900184

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
caucasian, male healthy subjects of 18 to 45 years of age (inclusive).
Description

Caucasians | Gender | Healthy Volunteers | Age

Data type

boolean

Alias
UMLS CUI [1]
C0043157
UMLS CUI [2]
C0079399
UMLS CUI [3]
C1708335
UMLS CUI [4]
C0001779
body weight ≥50 kg, with a body mass index calculated as weight in kg/(height in m2) from 18 to 27 kg/m2 at screening.
Description

Body Weight | Body mass index

Data type

boolean

Alias
UMLS CUI [1]
C0005910
UMLS CUI [2]
C1305855
subjects will sign and date an informed consent form before any study-specific screening procedure is performed.
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
healthy, as determined by the investigator on the basis of medical history, physical examination findings, clinical laboratory test results, vital sign measurements, and digital 12 lead ecg readings.
Description

Healthy Medical History | Healthy Physical Examination | Healthy Laboratory test result | Healthy Vital signs measurements | Healthy 12 lead ECG

Data type

boolean

Alias
UMLS CUI [1,1]
C3898900
UMLS CUI [1,2]
C0262926
UMLS CUI [2,1]
C3898900
UMLS CUI [2,2]
C0031809
UMLS CUI [3,1]
C3898900
UMLS CUI [3,2]
C0587081
UMLS CUI [4,1]
C3898900
UMLS CUI [4,2]
C2963216
UMLS CUI [5,1]
C3898900
UMLS CUI [5,2]
C0430456
non-smoker or smoker of fewer than 5 cigarettes per day as determined by history. must be able to abstain from smoking during the inpatient stay.
Description

Non-smoker | Tobacco use Number of cigarettes per day | Ability Refrain from Smoking

Data type

boolean

Alias
UMLS CUI [1]
C0337672
UMLS CUI [2,1]
C0543414
UMLS CUI [2,2]
C3694146
UMLS CUI [3,1]
C0085732
UMLS CUI [3,2]
C4086797
have a high probability for compliance with and completion of the study.
Description

Probability High Compliance behavior | Probability High Completion of clinical trial

Data type

boolean

Alias
UMLS CUI [1,1]
C0033204
UMLS CUI [1,2]
C0205250
UMLS CUI [1,3]
C1321605
UMLS CUI [2,1]
C0033204
UMLS CUI [2,2]
C0205250
UMLS CUI [2,3]
C2732579
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
any significant cardiovascular, hepatic, renal, respiratory, gastrointestinal, endocrine, immunologic, dermatological, haematological, neurologic, psychiatric disease or history of any clinically important drug allergy.
Description

Cardiovascular Diseases | Liver diseases | Kidney Diseases | Respiration Disorders | Gastrointestinal Diseases | Endocrine System Diseases | Immune System Diseases | Dermatologic disorders | Hematological Disease | Nervous system disorder | Mental disorders | Drug Allergy

Data type

boolean

Alias
UMLS CUI [1]
C0007222
UMLS CUI [2]
C0023895
UMLS CUI [3]
C0022658
UMLS CUI [4]
C0035204
UMLS CUI [5]
C0017178
UMLS CUI [6]
C0014130
UMLS CUI [7]
C0021053
UMLS CUI [8]
C0037274
UMLS CUI [9]
C0018939
UMLS CUI [10]
C0027765
UMLS CUI [11]
C0004936
UMLS CUI [12]
C0013182
acute disease state within 7 days before study day 1.
Description

Acute illness

Data type

boolean

Alias
UMLS CUI [1]
C4061114
history of drug abuse within 1 year before study day 1.
Description

Drug abuse

Data type

boolean

Alias
UMLS CUI [1]
C0013146
history of alcoholism within 1 year before day 1. consumption of more than 50 g of ethanol per day.
Description

Alcoholic Intoxication, Chronic | Alcohol consumption Gram per day

Data type

boolean

Alias
UMLS CUI [1]
C0001973
UMLS CUI [2,1]
C0001948
UMLS CUI [2,2]
C0439417
positive serologic findings for human immunodeficiency virus antibodies, hepatitis b surface antigen, and/or hepatitis c virus antibodies.
Description

Serology positive HIV Antibodies | Serology positive Hepatitis B Surface Antigens | Serology positive Hepatitis C Antibodies

Data type

boolean

Alias
UMLS CUI [1,1]
C0242089
UMLS CUI [1,2]
C0019683
UMLS CUI [2,1]
C0242089
UMLS CUI [2,2]
C0019168
UMLS CUI [3,1]
C0242089
UMLS CUI [3,2]
C0166049
positive findings of urine drug screen (e.g., amphetamines, barbiturates, benzodiazepines, cannabinoids, cocaine, methadone, opiates, mdma)
Description

Urine drug screen positive | Amphetamines | Barbiturates | Benzodiazepines | Cannabinoids | Cocaine | Methadone | Opiates | Ecstasy

Data type

boolean

Alias
UMLS CUI [1]
C0743300
UMLS CUI [2]
C0002667
UMLS CUI [3]
C0004745
UMLS CUI [4]
C0005064
UMLS CUI [5]
C0006864
UMLS CUI [6]
C0009170
UMLS CUI [7]
C0025605
UMLS CUI [8]
C0376196
UMLS CUI [9]
C0115471
history of any clinically important drug allergy.
Description

Drug Allergy

Data type

boolean

Alias
UMLS CUI [1]
C0013182
prohibited treatments: use of any investigational drug within 90 days or prescription drug within 30 days before investigational medical product administration.
Description

Therapeutic procedure Illicit | Investigational New Drugs Recent | Prescription Drugs Recent

Data type

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0332266
UMLS CUI [2,1]
C0013230
UMLS CUI [2,2]
C0332185
UMLS CUI [3,1]
C0304227
UMLS CUI [3,2]
C0332185
consumption of any caffeine-containing products in excess of 6 cups per day (or equivalent), of grapefruit, grapefruit-containing products, or alcoholic beverages within 24 hours before study day 1.
Description

Pharmaceutical Preparations Containing Caffeine | Consumption Excessive cups per day | GRAPEFRUIT EXTRACT | Pharmaceutical Preparations Containing GRAPEFRUIT EXTRACT | Alcoholic Beverages

Data type

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0332256
UMLS CUI [1,3]
C0006644
UMLS CUI [2,1]
C0009830
UMLS CUI [2,2]
C0442802
UMLS CUI [2,3]
C0560654
UMLS CUI [3]
C0440280
UMLS CUI [4,1]
C0013227
UMLS CUI [4,2]
C0332256
UMLS CUI [4,3]
C0440280
UMLS CUI [5]
C0001967
use of any over-the-counter drugs including herbal supplements (except for the occasional use of acetaminophen [paracetamol], aspirin and vitamins ≤100% recommended daily allowance) within 7 days before investigational medicinal product administration.
Description

Drugs, Non-Prescription | Herbal Supplements | Exception Acetaminophen | Exception Aspirin | Exception Vitamins

Data type

boolean

Alias
UMLS CUI [1]
C0013231
UMLS CUI [2]
C1504473
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0000970
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0004057
UMLS CUI [5,1]
C1705847
UMLS CUI [5,2]
C0042890
donation of blood (i.e. 450 ml) within 90 days before study day 1.
Description

Blood Donation Amount Timespan

Data type

boolean

Alias
UMLS CUI [1,1]
C0005794
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0872291
Back to the top of the page

Similar models

Eligibility Essential Hypertension NCT01900184

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Caucasians | Gender | Healthy Volunteers | Age
Item
caucasian, male healthy subjects of 18 to 45 years of age (inclusive).
boolean
C0043157 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
C1708335 (UMLS CUI [3])
C0001779 (UMLS CUI [4])
Body Weight | Body mass index
Item
body weight ≥50 kg, with a body mass index calculated as weight in kg/(height in m2) from 18 to 27 kg/m2 at screening.
boolean
C0005910 (UMLS CUI [1])
C1305855 (UMLS CUI [2])
Informed Consent
Item
subjects will sign and date an informed consent form before any study-specific screening procedure is performed.
boolean
C0021430 (UMLS CUI [1])
Healthy Medical History | Healthy Physical Examination | Healthy Laboratory test result | Healthy Vital signs measurements | Healthy 12 lead ECG
Item
healthy, as determined by the investigator on the basis of medical history, physical examination findings, clinical laboratory test results, vital sign measurements, and digital 12 lead ecg readings.
boolean
C3898900 (UMLS CUI [1,1])
C0262926 (UMLS CUI [1,2])
C3898900 (UMLS CUI [2,1])
C0031809 (UMLS CUI [2,2])
C3898900 (UMLS CUI [3,1])
C0587081 (UMLS CUI [3,2])
C3898900 (UMLS CUI [4,1])
C2963216 (UMLS CUI [4,2])
C3898900 (UMLS CUI [5,1])
C0430456 (UMLS CUI [5,2])
Non-smoker | Tobacco use Number of cigarettes per day | Ability Refrain from Smoking
Item
non-smoker or smoker of fewer than 5 cigarettes per day as determined by history. must be able to abstain from smoking during the inpatient stay.
boolean
C0337672 (UMLS CUI [1])
C0543414 (UMLS CUI [2,1])
C3694146 (UMLS CUI [2,2])
C0085732 (UMLS CUI [3,1])
C4086797 (UMLS CUI [3,2])
Probability High Compliance behavior | Probability High Completion of clinical trial
Item
have a high probability for compliance with and completion of the study.
boolean
C0033204 (UMLS CUI [1,1])
C0205250 (UMLS CUI [1,2])
C1321605 (UMLS CUI [1,3])
C0033204 (UMLS CUI [2,1])
C0205250 (UMLS CUI [2,2])
C2732579 (UMLS CUI [2,3])
Item Group
C0680251 (UMLS CUI)
Cardiovascular Diseases | Liver diseases | Kidney Diseases | Respiration Disorders | Gastrointestinal Diseases | Endocrine System Diseases | Immune System Diseases | Dermatologic disorders | Hematological Disease | Nervous system disorder | Mental disorders | Drug Allergy
Item
any significant cardiovascular, hepatic, renal, respiratory, gastrointestinal, endocrine, immunologic, dermatological, haematological, neurologic, psychiatric disease or history of any clinically important drug allergy.
boolean
C0007222 (UMLS CUI [1])
C0023895 (UMLS CUI [2])
C0022658 (UMLS CUI [3])
C0035204 (UMLS CUI [4])
C0017178 (UMLS CUI [5])
C0014130 (UMLS CUI [6])
C0021053 (UMLS CUI [7])
C0037274 (UMLS CUI [8])
C0018939 (UMLS CUI [9])
C0027765 (UMLS CUI [10])
C0004936 (UMLS CUI [11])
C0013182 (UMLS CUI [12])
Acute illness
Item
acute disease state within 7 days before study day 1.
boolean
C4061114 (UMLS CUI [1])
Drug abuse
Item
history of drug abuse within 1 year before study day 1.
boolean
C0013146 (UMLS CUI [1])
Alcoholic Intoxication, Chronic | Alcohol consumption Gram per day
Item
history of alcoholism within 1 year before day 1. consumption of more than 50 g of ethanol per day.
boolean
C0001973 (UMLS CUI [1])
C0001948 (UMLS CUI [2,1])
C0439417 (UMLS CUI [2,2])
Serology positive HIV Antibodies | Serology positive Hepatitis B Surface Antigens | Serology positive Hepatitis C Antibodies
Item
positive serologic findings for human immunodeficiency virus antibodies, hepatitis b surface antigen, and/or hepatitis c virus antibodies.
boolean
C0242089 (UMLS CUI [1,1])
C0019683 (UMLS CUI [1,2])
C0242089 (UMLS CUI [2,1])
C0019168 (UMLS CUI [2,2])
C0242089 (UMLS CUI [3,1])
C0166049 (UMLS CUI [3,2])
Urine drug screen positive | Amphetamines | Barbiturates | Benzodiazepines | Cannabinoids | Cocaine | Methadone | Opiates | Ecstasy
Item
positive findings of urine drug screen (e.g., amphetamines, barbiturates, benzodiazepines, cannabinoids, cocaine, methadone, opiates, mdma)
boolean
C0743300 (UMLS CUI [1])
C0002667 (UMLS CUI [2])
C0004745 (UMLS CUI [3])
C0005064 (UMLS CUI [4])
C0006864 (UMLS CUI [5])
C0009170 (UMLS CUI [6])
C0025605 (UMLS CUI [7])
C0376196 (UMLS CUI [8])
C0115471 (UMLS CUI [9])
Drug Allergy
Item
history of any clinically important drug allergy.
boolean
C0013182 (UMLS CUI [1])
Therapeutic procedure Illicit | Investigational New Drugs Recent | Prescription Drugs Recent
Item
prohibited treatments: use of any investigational drug within 90 days or prescription drug within 30 days before investigational medical product administration.
boolean
C0087111 (UMLS CUI [1,1])
C0332266 (UMLS CUI [1,2])
C0013230 (UMLS CUI [2,1])
C0332185 (UMLS CUI [2,2])
C0304227 (UMLS CUI [3,1])
C0332185 (UMLS CUI [3,2])
Pharmaceutical Preparations Containing Caffeine | Consumption Excessive cups per day | GRAPEFRUIT EXTRACT | Pharmaceutical Preparations Containing GRAPEFRUIT EXTRACT | Alcoholic Beverages
Item
consumption of any caffeine-containing products in excess of 6 cups per day (or equivalent), of grapefruit, grapefruit-containing products, or alcoholic beverages within 24 hours before study day 1.
boolean
C0013227 (UMLS CUI [1,1])
C0332256 (UMLS CUI [1,2])
C0006644 (UMLS CUI [1,3])
C0009830 (UMLS CUI [2,1])
C0442802 (UMLS CUI [2,2])
C0560654 (UMLS CUI [2,3])
C0440280 (UMLS CUI [3])
C0013227 (UMLS CUI [4,1])
C0332256 (UMLS CUI [4,2])
C0440280 (UMLS CUI [4,3])
C0001967 (UMLS CUI [5])
Drugs, Non-Prescription | Herbal Supplements | Exception Acetaminophen | Exception Aspirin | Exception Vitamins
Item
use of any over-the-counter drugs including herbal supplements (except for the occasional use of acetaminophen [paracetamol], aspirin and vitamins ≤100% recommended daily allowance) within 7 days before investigational medicinal product administration.
boolean
C0013231 (UMLS CUI [1])
C1504473 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0000970 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0004057 (UMLS CUI [4,2])
C1705847 (UMLS CUI [5,1])
C0042890 (UMLS CUI [5,2])
Blood Donation Amount Timespan
Item
donation of blood (i.e. 450 ml) within 90 days before study day 1.
boolean
C0005794 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0872291 (UMLS CUI [1,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial